Mirati Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

42,649

Value ($000)

1,858

Weight

0.0%

2020 Q4 - 2023 Q3 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	1,858	0.0%	42,649	9/30/2023
2023 Q2	8/10/2023	4,233	0.0%	117,151	6/30/2023
2023 Q1	5/10/2023	5,075	0.0%	136,486	3/31/2023
2021 Q4	2/10/2022	3,044	0.0%	20,751	12/31/2021
2021 Q1	5/13/2021	762	0.0%	4,448	3/31/2021
2020 Q4	2/16/2021	662	0.0%	3,013	12/31/2020